Recent Posts
- Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
- Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
- Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
- Elutia to Participate in Upcoming Investor Conferences
- Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption